✦ LIBER ✦

Pharmacological characteristics of dopamine receptors involved in the dual effect of dopamine agonists on yawning behaviour in rats

✍ Scribed by Philippe Protais; Isabelle Dubuc; Jean Costentin

Book ID: 115877974
Publisher: Elsevier Science
Year: 1983
Tongue: English
Weight: 666 KB
Volume: 94
Category: Article
ISSN: 0014-2999
DOI: 10.1016/0014-2999(83)90416-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine and sexual behaviour in female

Dopamine and sexual behaviour in female rats. Effects of dopamine receptor agonists and sulpiride

✍ Everitt, Barry J.; Fuxe, Kjell 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Role of dopamine receptors in the dual e

Role of dopamine receptors in the dual effect of naloxone on quinpirole-induced yawning in morphine pretreated rats

✍ Alexander Zharkovsky; Jaana Moisio; Toomas Kivastik; Liisa Ahtee 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 567 KB

Potentiation by serotonergic inhibition

Potentiation by serotonergic inhibition of yawning induced by dopamine receptor agonists in rats

✍ Shin-Ichiro Matsumoto; Katsushi Yamada; Mariko Nagashima; Naohiro Matsuo; Koichi 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Evaluation of dopamine receptor involvem

Evaluation of dopamine receptor involvement in rat feeding behaviour

✍ Zarrindast, M.R.; Owji, A.A.; Hosseini-Nia, T. 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 468 KB

Influence of idazoxan on the dopamine D2

Influence of idazoxan on the dopamine D2 receptor agonist-induced behavioural effects in rats

✍ Francesca Ferrari; Daniela Giuliani 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 620 KB

Involvement of septal and striatal dopam

Involvement of septal and striatal dopamine D-2 receptors in yawning behavior in rats

✍ Katsushi Yamada; Mariko Tanaka; Kazuhiko Shibata; Tatsuo Furukawa 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 561 KB

A behavioral study was performed in an attempt to understand the neuronal mechanisms involved in yawning behavior in rats. Subcutaneous injections of low doses of apomorphine (0.054.25 mg/kg) or piribedil (0.2-1.0 mg/kg), which preferentially activate presynaptic dopamine autoreceptors at those dose